Percutaneous coronary intervention aturrrrr
Transforming complex PCI procedures into confident care
IVUS interpretation
Visualize the best path forward
Cross-sectional images help assess presence and extent of disease, plaque geometry and morphology, guide wire position during lesion crossing, and stent position post-treatment.
Demonstrated results in PCI.
135
more hours of operational availability
135 more hours in average of operational availability per year.12 Gain time to treat more patients in your interventional suite.
Read more91%
gree that the new touch screen module improves usability
91% of Azurion users think the enhanced touch screen module technology increases the ease of use when switching between compatible applications (e.g., X-ray, IFR/FFR, IVUS, hemo, etc.) during interventions compared to their current system.13
Downloadtest
test
test
Read more
Perform ultra-low contrast percutaneous coronary intervention procedures with greater confidence
Benefits:
- Clearly identify coronary artery disease with imaging, physiology, co-registration and software available in one platform
- Perform tasks such as 2D-QA during fluoroscopy or exposure with instant parallel working functionality
- Make fast, informed clinical decisions by going beyond the angiogram to complete your view of the target vessel
- Continuously monitor patients and improve cath lab workflows with hemo monitoring and data management
Key Features:
- Easy access to applications and imaging tools to improve cath lab performance
- Solutions for every step of coronary procedures, from diagnosis to restoring vessel patency
- Scalable platform that will be ready to provide you with new innovations and tools as they become available in the future
Image gallery
- The IntraSight applications platform is where imaging, physiology, co-registration* and software all come together to clearly identify coronary and peripheral artery disease.
Enabling technologies
Metus conubia lectus felis hendrerit pulvinar ullamcorper. Felis nec montes morbi dolor vitae sociosqu interdum! Magnis justo aliquet
Navigation discription
- Co-registration tools available within IntraSight 7 configuration via SyncVision
- Patel M. “Cost-effectiveness of instantaneous wave-Free Ratio (iFR) compared with Fractional Flow Reserve (FFR) to guide coronary revascularization decisionmaking.” Late-breaking Clinical Trial presentation at ACC on March 10, 2018.